Despite a challenging year with many COVID-19-related interruptions, medtech companies’ deal-making “firepower” is at an all-time high, which positions the sector well for a very active mergers and acquisitions market in 2021, according to EY’s recent M&A Firepower report.
In spite of many procedures getting postponed due to COVID-19 in 2020, medtech’s firepower, which EY defines as a company’s...